688029 南微醫學
按盤價 
83.000 +1.480 (+1.816%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 12.896 | 14.876 | 14.215 | 10.719 | 11.694 |
| 總資產報酬率 ROA (%) | 10.214 | 12.063 | 11.728 | 8.786 | 9.641 |
| 投入資產回報率 ROIC (%) | 12.122 | 14.271 | 13.704 | 10.467 | 11.551 | 邊際利潤分析 |
| 銷售毛利率 (%) | 64.550 | 67.653 | 64.504 | 60.950 | 64.181 |
| 營業利潤率 (%) | 26.310 | 23.931 | 23.001 | 18.391 | 18.862 |
| 息稅前利潤/營業總收入 (%) | 23.288 | 22.140 | 20.198 | 15.514 | 20.454 |
| 淨利潤/營業總收入 (%) | 22.268 | 20.617 | 20.514 | 16.809 | 16.918 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 99.684 | 104.751 | 98.627 | 93.493 | 86.167 |
| 價值變動淨收益/利潤總額(%) | 1.672 | 3.036 | 4.928 | 11.752 | 17.328 |
| 營業外收支淨額/利潤總額(%) | 0.051 | 0.055 | 1.813 | 1.009 | 2.692 | 償債能力分析 |
| 流動比率 (X) | 4.024 | 4.118 | 5.067 | 5.343 | 4.665 |
| 速動比率 (X) | 3.299 | 3.452 | 4.264 | 4.327 | 4.010 |
| 資產負債率 (%) | 18.270 | 18.417 | 16.448 | 15.910 | 17.662 |
| 帶息債務/全部投入資本 (%) | 5.900 | 2.141 | 2.199 | 1.131 | 0.318 |
| 股東權益/帶息債務 (%) | 1,562.294 | 4,483.795 | 4,358.737 | 8,580.466 | 30,894.838 |
| 股東權益/負債合計 (%) | 429.242 | 434.663 | 499.910 | 520.536 | 458.858 |
| 利息保障倍數 (X) | -7.675 | -12.267 | -6.258 | -5.064 | 19.103 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 55.322 | 55.137 | 51.670 | 57.921 | 51.787 |
| 存貨周轉天數 (天) | 185.984 | 213.687 | 228.962 | 223.846 | 157.347 |
| 備註： | 即時報價更新時間為 29/10/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
